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2Interpretive summary:1
Expression of genes involved in the somatotropic axis in New Zealand Holstein2
Friesian (NZHF) compared to the North American Holstein Friesian (NAHF) during3
early- and mid-lactation. By McCarthy et al. The somatotropic axis plays a key role in4
nutrient partitioning and milk production. During early lactation cows experience5
negative energy balance, and this is associated with uncoupling of the somatotropic6
axis.. In this study we report that NAHF cows have a longer period of uncoupling7
compared to NZHF cows as a result of altered expression of key genes in the axis,8
consistent with prolonged partitioning of nutrients towards milk production and9
reduced reproductive performance. Both strain of Holstein-Friesian cow and stage of10
lactation influence the functionality of the somatotropic axis.11
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ABSTRACT3
Differences in genetic selection criteria for dairy cows internationally have led to4
divergence in the Holstein Friesian breed. The objective of this study was to compare5
hepatic expression of genes of the somatotropic axis in the North American Holstein6
Friesian (NAHF) and the New Zealand Holstein Friesian (NZHF) strains of dairy cow7
at early- and mid-lactation. Mature cows of both NAHF (n=10) and NZHF (n=10)8
strains were selected. Liver tissue was collected by percutaneous punch biopsy from9
all cows at 35 and 140 days postpartum, representing early- and mid-lactation,10
respectively. Total RNA was extracted and the hepatic expression of genes involved11
in the control of the somatotropic axis was examined. Abundance of insulin-like12
growth factor-1 (IGF-1) mRNA was greater in the NZ strain concomitant with a13
tendency for increased expression of acid labile subunit (ALS) mRNA. Across strains,14
mRNA abundance of insulin-like growth factor-binding protein-1 and -2 (IGFBP-115
and IGFBP-2) and growth hormone receptor 1A (GHR1A) decreased from day 35 to16
140 postpartum, whereas expression of IGF-1 and ALS tended to increase.17
Abundance of SOCS3 mRNA was increased at d 140 postpartum. Both strain of18
Holstein-Friesian cow and stage of lactation influence expression of genes controlling19
the somatotropic axis in hepatic tissue.20
21
(Keywords: Holstein-Friesian, liver, gene expression, somatotropic)22
23
INTRODUCTION24
Strain comparison studies in New Zealand and Ireland have reported lesser milk25
volume, greater BCS throughout lactation and superior reproductive performance for26
4the New Zealand Holstein Friesian (NZHF) compared to North American Holstein1
Friesian (NAHF) (Horan et al., 2005b).The NAHF strain has been selected for2
increased milk yield, body size and angularity in a production system based on year-3
round calving and greater levels of concentrate supplementation, with little emphasis4
on traits such as fertility (Hoekstra et al., 1994; Pryce and Veerkamp, 2001;5
Macdonald et al., 2007). The NZHF strain, on the other hand, has been selected for6
increased concentrations of milk fat and protein, reduced maintenance energy costs7
and improved fertility and survival traits under pasture-based systems of production.8
9
The occurrence of negative energy balance (NEB) during early lactation is a widely10
reported phenomenon (Bauman and Currie, 1980). During NEB, mobilization of body11
reserves is necessary to meet the energy requirements of lactogenesis. It is generally12
accepted that the growth hormone-insulin-like growth factor (or somatotropic) axis in13
the liver becomes uncoupled, whereby elevated plasma growth hormone (GH)14
concentrations fail to stimulate an increase in hepatic insulin-like growth factor-115
(IGF-1) synthesis (Thissen et al., 1994; Fenwick et al., 2008; Lucy, 2008). IGF-116
plays a critical role in stimulating the anabolic and mitogenic activity of GH in17
various tissues (Laron, 2001). The liver is the major source of circulating insulin-like18
growth factor’s (Miller et al., 1981; Schwander et al., 1983; Thissen et al., 1994), and19
therefore this organ plays a central role in the metabolism of the cow.20
21
Numerous reports have suggested that nutritionally compromised cows have reduced22
systemic concentrations of insulin and IGF-I (Patton et al., 2006; Lucy, 2008), and23
Lucy et al. (2009) reported that NAHF cows experience an uncoupling of the24
somatotropic axis in conjunction with reduced BCS. It has been reported that25
irreversible glucose loss leads to some degree of uncoupling of the somatotropic axis,26
5as plasma concentrations of IGF-1 decline concomitant with a reduction in hepatic1
mRNA abundance of IGF-1 and GH receptor (GHR) (Meier et al., 2008).2
Furthermore, insulin is also hypothesised to be a key metabolic signal regulating the3
coupling of the somatotropic axis (Butler et al., 2003).4
5
Current knowledge indicates that the IGF system is composed of: two ligands (IGF-16
and IGF-2); two receptors (IGF-1R and IGF-2R); six binding proteins (IGFBP-1-6)7
and the IGF binding protein-acid labile subunit (IGFBP-ALS). The somatotropic axis8
also includes the GHR, which is expressed as multiple mRNA variants in different9
tissues. In liver, the growth hormone receptor 1A (GHR1A) variant is the principal10
GHR mRNA transcript, and its expression plays a key role in the coupling of the11
somatotropic axis. The effects of GH on the IGF system are primarily mediated by the12
Janus kinase 2 (JAK2) protein and two members of a family of DNA binding proteins13
called signal transducers and activators of transcription (STAT), namely STAT5a and14
STAT5b (Udy et al., 1997; Teglund et al., 1998).15
16
Previous studies have demonstrated that systemic concentrations of the metabolic17
hormone IGF-1 in early lactation are positively associated with subsequent calving to18
service interval and ultimately pregnancy outcome in dairy cattle (Taylor et al., 2004;19
Patton et al., 2007; Wathes et al., 2007). Therefore, a greater understanding of the20
molecular regulation of hepatic expression of IGF-1 and its associated molecules is of21
critical importance to elucidating how this system may influence cow fertility.22
Recently it was reported that although NA and NZ strains of Holstein Friesian cows23
had similar postpartum EB profiles, plasma concentrations of IGF-1 were greater in24
NZHF cows during the post-transition period (30 – 90 days post calving) (Patton et25
al., 2008). Thus the objective of this study was to determine the effect of strain of26
6Holstein Friesian cow on the transcriptional regulation of key hepatic genes1
controlling the somatotropic axis during early- and mid- lactation.2
3
MATERIALS AND METHODS4
Animals, Experimental Design and Tissue Collection5
All experimental procedures involving animals were licensed by the Department of6
Health and Children, Ireland, in accordance with the cruelty to animals act (Ireland7
1897) and European Community Directive 86/609/EC. The animal model used in this8
study has been previously described (Horan et al., 2005a). Briefly, the NA strain was9
developed by breeding the top 50% of cows in the Moorepark herd (based on10
pedigree index for milk production) with 5 NA Holstein Friesian sires, selected as the11
highest available in Ireland for pedigree index for milk production. The animals in the12
NZ strain were imported from New Zealand as embryos and implanted into Holstein13
heifers. These embryos were generated by mating high-genetic-merit NZ Holstein14
Friesian cows with five high genetic-merit NZ Holstein Friesian sires (based on15
Breeding Worth; the New Zealand genetic evaluation system). For the purposes of the16
current study, 10 mature NAHF and 10 mature NZHF cows were selected from their17
respective strains within the Moorepark strain comparison study (Horan et al., 2005a).18
Milk production, DMI, energy balance, and blood hormone and metabolite profiles of19
these animals have been previously reported (Patton et al., 2008). Briefly, NA cows20
had greater peak milk yields and total lactation milk yields (7387 v 6208 kg; s.e.d. =21
359), lower milk fat and similar protein concentrations compared with the NZ cows.22
BCS tended to be lower for NA cows and this strain tended to have greater DMI (17.223
v 15.7 kg/day; P = 0.07) for week 1 to 20 of lactation. Similar magnitude of EB nadir24
was recorded for NA and NZ strains (- 6.88 v – 7.31 UFL/day; P = 0.72). All cows25
were managed in a similar manner as a single group throughout the lactation period.26
7The pre partum diet comprised ad libitum grass silage, with 2 kg per day of the1
lactating concentrate introduced from 2 weeks prior to the expected calving date. The2
early post partum diet consisted of ad libitum grass silage and 8 kg of concentrate.3
From March 20th, all lactating cows were offered ad libitum zero-grazed grass (L.4
perenne spp) supplemented with 4 kg concentrate. Grass was harvested and fed each5
morning. The diet offered was designed to simulate normal feeding practices in6
seasonal-calving systems of milk production in Ireland. All cows were fed ad libitum7
grass silage and 8 kg of concentrate at the time of the first biopsy, and ad libitum8
zero-grazed grass supplemented with 4 kg concentrate at the time of the second9
biopsy. The concentrate ingredients and the chemical composition of the concentrate10
and forages has been reported previously (Patton et al., 2008).11
12
Liver tissue was collected from all cows at 35 (± 0.5) days and 140 (± 2.4) days13
postpartum by percutaneous punch biopsy as described by Smith et al. (1997). Briefly,14
a biopsy site between the 11th and 12th ribs was shaved, sanitized with 7.5% povidone-15
iodine and 70% ethanol, and anesthetized (lidocaine HCl: 2%). An incision of16
approximately 1 cm was made through the skin and the biopsy instrument was used to17
pierce the intercostal muscles and peritoneum. Approximately 1-1.5 g of liver tissue18
was collected, washed with sterile PBS, snap frozen in liquid nitrogen, and stored at –19
80 C until further analysis.20
21
RNA extraction and cDNA synthesis22
Total RNA was isolated from 100 mg of the frozen liver biopsy using TRIzol reagent23
and chloroform and subsequently precipitated using isopropanol. RNA quantity and24
purity was determined by absorbance at 260 nm using a NanoDrop ND-100025
spectrophotometer (NanoDrop Technologies Inc., DE). All RNA samples had an26
8A260/280 absorbance between 1.8 and 2. RNA quality and integrity was also assessed by1
measuring the 18S/28S ratio, and RNA integrity number (RIN) using automated2
capillary gel electrophoresis on a Bioanalyser 2100 with the RNA 6000 Nano3
LabChip kit according to manufacturers instructions (Agilent Technologies Ireland4
Ltd., Dublin, Ireland). RNA samples with18S/28S ratios ranging from 1.8 and 2.0 and5
RINs of between 8 and 10 were deemed high quality and suitable for gene expression6
analysis.7
8
Five micrograms of total RNA was treated for potential genomic DNA carryover with9
RNase-free DNase according to the manufacturers’ instructions (Promega10
Corporation, Madison, WI, USA). RNA was purified using the RNeasy mini kit in11
accordance with instructions supplied (QIAGEN, Crawley, West Sussex, UK).12
Complimentary DNA (cDNA) was obtained by reverse transcribing 1 g of DNase-13
treated RNA using reverse transcriptase and 500 ng random hexamer primers in a 2014
l reaction (Reverse transcription system; Promega WI, USA). A mastermix of15
reagents was prepared for the above reaction to minimize potential variation from16
pipetting. Selected negative control samples were also prepared by including all17
reagents as above minus the reverse transcriptase. A quantity of 0.39 ng of kanamycin18
resistance gene mRNA (Promega, WI, USA) was spiked into each sample as an19
exogenous control.20
21
Primer Design and optimization of real –time RT-PCR22
Real-time PCR assays were designed for genes of the somatotropic axis and their23
transcriptional regulators. Gene specific primer sequences were as previously24
described (Fenwick et al., 2008) or were designed (Table 1) online using the Primer325
web based software (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) based26
9on coding regions of core bovine nucleotide sequences on NCBI1
(http://www.ncbi.nlm.nih.gov/). Primer alignment specificity and compatibility was2
determined using the BLAST search tool from NCBI3
(http://www.ncbi.nlm.nih.gov/BLAST/) and Amplify software (v3.1). All4
oligonucleotides were commercially synthesized as highly purified, salt free products5
(Sigma-Aldrich Ireland Ltd., Dublin, Ireland). Primers were first tested by6
conventional PCR amplification using Platinum PCR supermix containing Taq7
polymerase (Invitrogen; Invitrogen Ltd., Paisley, UK) and the addition of 50-75 ng8
DNase treated reverse-transcribed RNA and primers (20 μM), to optimize9
amplification conditions. Once optimized, external standards were amplified from10
cDNAs identical to real-time PCR products and purified using QIA quick PCR11
purification columns (QIAGEN, Crawley, West Sussex, UK). Concentrations of12
purified cDNA product was determined using the NanoDrop ND-100013
spectrophotometer (NanoDrop Technologies Inc., DE) and the presence of a single14
product confirmed by 1.5 % (w/v) agarose gel electrophoresis. Standards for each15
gene analysed were diluted in nuclease-free water (Promega, WI, USA) and16
concentrations ranged from 1 × 10-1 – 1 × 10-9 ng/µl DNA. All amplified PCR17
products from this study were also sequenced to verify their identity (Macrogen,18
Nucleics Pty Ltd, Victoria, Australia). In all cases, the DNA sequence of the gene19
being verified was 100% identical to the published sequence.20
21
Real-Time RT-PCR22
The stability of the expression of several control or housekeeping genes across all23
samples in this study was investigated, including GAPDH, β-actin, RPL-19 and24
18SrRNA as part of a preliminary study. Resulting expression data were analysed25
using GeNorm software package and as statistically significant differences in26
10
expression of these genes existed between samples, it was concluded that none of1
these genes were suitable as a housekeeping gene and thus relative real time PCR2
could therefore not be conducted. Thus, an absolute real-time RT-PCR methodology3
employing an exogenous reference control to normalize real-time PCR results was4
performed to measure the expression of genes involved in the somatotropic axis5
(Table 1), using the ABI 7500 Fast real-Time PCR System with Power SYBR®6
Master Mix (Applied Biosystems, Warrington, UK). The application of this method7
has previously been described (Smith et al., 2003; Gilsbach et al., 2006). The8
exogenous control gene employed in this study was the kanamycin resistance gene as9
previously reported (Fenwick et al., 2008). Real-time RT-PCR was also performed to10
detect expression of the exogenous kanamycin control in generated cDNA. Reactions11
were carried out in a 96 well plate format and prepared in a total volume of 20 l,12
with 1 g cDNA, 10 l Power SYBR® master mix and 1 l of 20 M forward and13
reverse primer mix. External standards were run on the same plate in triplicate. Non-14
template controls were included on every plate for each gene product. To minimize15
variation, all samples included in each analysis were derived from the same cDNA16
batch, prepared under the same conditions, and samples were run in duplicate.17
Thermal cycling conditions applied to each assay consisted of an initial Taq activation18
step at 95 ˚C for 15 min followed by 38 cycles of 95 C for 15 s, 54.3-62.3 C for 3019
s, followed by an amplicon dissociation stage (95 C for 15 s, 60 C for 1 min,20
increasing 0.5 C/cycle until 95 C was reached). All samples for a particular gene21
were assayed on the same plate, thereby eliminating intra-assay variation, and22
specificity of the reaction products was also confirmed by dissociation curve analysis23
and gel electrophoresis.24
25
11
Statistical analysis1
Gene expression data were log transformed for normalization of variances and were2
analysed using the MIXED procedure of SAS (SAS, 2003). Cow was treated as a3
random effect with terms for day and strain and their interaction included as fixed4
effects in the model. The expression of several internal control genes was5
investigated, including GAPDH, β-actin, RPL-19 and 18SrRNA; however, no suitable6
internal control gene was identified due to consistently high variation between7
samples. Expression of the kanamycin resistance gene was used as a covariate and8
accounts for the combined effects of pipetting, RT efficiency and the presence of any9
contaminants that could inhibit the PCR reaction. For comparison of expression data,10
absolute values expressed as pg μg-1 reverse-transcribed RNA were derived from the11
mean Ct value of all unknown samples. The cut-off for significant effects on gene12
expression was a P value < 0.05, and differences in gene expression with P values13
between 0.05 and 0.15 were considered to have tendencies/trends towards14
significance. Pearson correlation analysis was carried out to determine relationships15
between plasma variables (glucose, non-esterified fatty acids, β-hydroxybutyrate,16
IGF-1) and mRNA abundance using the PROC CORR procedure in SAS. This17
analysis was carried out for each strain independently at d 35 and d 140.18
19
The r2 and amplification efficiency (E) values for real-time RT-PCR were calculated20
from linear regression analysis of log (input cDNA) versus threshold cycle number21
(Ct) plot (Table 4). The slope for each set of standards was used to determine E = 10(-22
1/slope) – 1. Intra-assay variation was determined from the average standard deviation23
across the quantification range and presented as percentage using the formula; ±%24
variation = [(E + 1)SD - 1] × 100 (Rutledge and Cote, 2003).25
26
12
RESULTS:1
2
Physiological measurements3
The EB, DMI, BCS, and plasma concentrations of metabolic hormones and4
metabolites of the animals used in the current study are discussed in detail by Patton5
et al. (2008). In summary, the NAHF and NZHF strains had similar mean daily EB6
during weeks 1-20 of lactation. The degree of BCS loss during weeks 1-20 of7
lactation was also similar for both strains; thereafter, the NZHF cows began to8
increase in BCS whereas NAHF cows continued to partition nutrients towards milk9
production, resulting in an increased BCS for NZHF by the end of lactation. Plasma10
insulin was greater for NAHF during the transition period, while plasma IGF-1 was11
similar for the strains during this time. Mean systemic concentrations of IGF-1 were12
increased to a greater extent in NZHF than NAHF during the post-transition period13
(Patton et al., 2008).14
15
mRNA abundance16
Results of the real-time RT-PCR analysis for independent time and strain effects are17
summarized in Table 2. Strain by time interaction effects are displayed in Table 3.18
IGF-1 gene expression was affected by strain of cow, with mRNA abundance 1.619
times greater in the NZHF strain (P < 0.05). The mRNA abundance of suppressor of20
cytokine signalling-3 (SOCS-3) was also 1.6 times greater for the NZ strain (P <21
0.01), and abundance of ALS mRNA tended to be greater for the NZ strain (1.67 fold22
increase; P = 0.06). There was no effect of strain on mRNA abundance of GHR1A,23
GHRtot, IGF-2, IGF-1R, IGF-2R, insulin receptor type-A (INSR), IGFBP-1-6, or the24
remaining transcription factors/signalling molecules examined (Table 2).25
26
13
Across strains, a number of genes were upregulated or downregulated at d 1401
compared to d 35 postpartum. Upregulated genes (fold increase in parentheses)2
included IGF-1R (1.5), estrogen receptor α (ERα) (1.5), and SOCS3 (2.48; all P <3
0.001), and trends for increased mRNA abundance were observed for ALS (1.66; P =4
0.11) and IGF-1 (1.6; P = 0.15). Downregulated genes (fold decrease in parentheses)5
included GHR1A (2.0; P < 0.05), IGF-2R (1.23; P < 0.01), IGFBP-1 (3.2; P < 0.01),6
IGFBP-2 (2.9; P < 0.001), IGFBP-3 (1.68; P < 0.05), INSR (1.24; P < 0.01),7
hepatocyte nuclear factor-4 alpha (HNF-4α) (2.35; P < 0.001), and a trend for8
reduced mRNA abundance of GHRtot (1.5; P = 0.15). There was no effect of stage of9
lactation on mRNA abundance of IGF-2, IGFBP4-6, JAK2 or STAT5b (all P > 0.2).10
11
Significant (P < 0.05) strain by time interactions were observed for IGFBP-4, INSR12
and SOCS3 genes. IGFBP-4 mRNA abundance tended to increase between d 35 and d13
140 postpartum in NZ cows, but tended to decline during this interval in NA cows.14
INSR mRNA abundance declined (P<0.05) by half in NA cows between d 35 and d15
140, but declined to a lesser extent in NZ cows. SOCS3 mRNA abundance increased16
significantly in the NA strain between d 35 and d 140, whereas a smaller non-17
significant increase was observed in the NZ strain (3.9 fold increase vs. 1.6 fold18
increase, NA vs. NZ, respectively; strain by time interaction, P < 0.01). A trend (P =19
0.06) for a strain by time interaction was observed for IGFBP-6, where mRNA20
abundance tended (P = 0.1) to increase between d 35 and d 140 for NZ cows, but21
remained constant in NA cows. Conversely, IGFBP3 decreased (P<0.05) in the NA22
cows between d 35 and d 140 (> 50% reduction), but remained relatively constant in23
NZ cows (strain by time interaction, P = 0.11). IGFBP-1 declined (P<0.05) in the NZ24
strain between d 35 and d 140, but a non-significant decrease (P = 0.3) was observed25
in the NA strain (2.2 fold decrease vs. 4.7 fold decrease, NA vs. NZ, respectively;26
14
strain by time interaction, P = 0.12). There was a trend for a strain by time interaction1
for mRNA abundance of IGF-2 (P = 0.15), as values appeared to decline in NAHF2
and increase in the NZHF between d 35 and d 140. However, within strain3
differences between d 35 and d 140 for IGF-2 mRNA abundance were non-significant4
(P > 0.6 for both strains). There were no trends for a strain by time interaction for the5
remaining genes examined (all P > 0.3).6
7
Correlation analysis8
Pearson correlation analysis indicated that circulating IGF-1 was positively correlated9
with IGFBP-5 mRNA abundance in the NZ strain (R = 0.74; P < 0.05), and negatively10
correlated with IGFBP-2 mRNA abundance in the NAHF strain (R = -0.65; P < 0.05).11
There were no relationships (P > 0.05) observed between plasma metabolites and the12
expression of genes analysed in the current study.13
14
15
DISCUSSION16
17
This study examined the expression of key genes of the somatotropic axis in two18
genetically divergent strains of Holstein Friesian dairy cows during early and mid-19
lactation. As such, the study provides a suitable model to compare the effects of20
selection for milk yield on expression of components of the somatotropic axis, and to21
examine the influence of these genes on physiological changes such as differences in22
milk yield and altered nutrient partitioning. The study is a comprehensive molecular23
investigation into the effects of strain of HF on the expression of these genes during24
early- and mid- lactation. Recently, Lucy et al. (2009) reported that NAHF cows25
experience a more severe uncoupling of the somatotropic axis in early lactation26
compared to NZHF cows. We did not observe the same differences in GHR1A and27
15
GHRtot expression in the current study; however NZ cows had increased mRNA1
abundance of IGF-1 compared to NA cows.2
3
Nearly all of the IGF-1 secreted by the liver (> 90%) circulates as a bound ternary4
complex with IGFBP-3 and ALS (Baxter, 1993; Clemmons, 1997). It has previously5
been reported that both strains of cows in our study had similar EB status for the first6
20 weeks of lactation (Patton et al., 2008). Under normal conditions, the ternary7
complex of IGF-1, IGFBP-3 (or BP-5) and ALS (almost all of which is produced by8
the liver) associate to prevent IGF degradation, prolong half-life in circulation and9
increase IGF-1 availability to other tissues (Boisclair et al., 2001). Both hepatic IGF-110
and ALS production are GH dependent (Kim et al., 2006) and occur via the11
JAK/STAT signalling cascade. The marked increase in IGF-1 mRNA expression12
observed in the NZHF compared to the NAHF strain coincided with increased ALS13
mRNA abundance in the NZHF strain. Interestingly, signalling molecules associated14
with activating IGF-1 gene transcription were not increased in the NZHF strain, but15
the mRNA abundance of the negative feedback molecule SOCS3 was greater in the16
NZHF compared to the NAHF strain. The observation that mRNA expression of both17
the IGF-1 and ALS genes was greater in NZHF compared to NAHF cows may18
indicate enhanced coupling of the somatotropic axis via the JAK/STAT pathway in19
the NZHF strain. The trend for a strain by time interaction for IGFBP-3, whereby20
IGFBP-3 mRNA abundance declined more than two fold in NAHF cows from d 35 to21
d 140, suggests that the proportion of the circulating IGF-1 in the stable ternary22
complex may be reduced in NAHF cows compared to the NZHF cows. It has recently23
been reported that feed restricted steers had greater degradation of IGF-1 in24
circulation as a result of reduced IGFBP-3 and ALS production in the liver (Wu et al.,25
2008).26
16
1
Patton et al. (2008) reported that plasma IGF-1 concentrations were higher in NZHF2
compared to NAHF cows, despite both strains having similar EB profiles, and NAHF3
cows having greater plasma insulin concentrations. This result was not consistent with4
other studies that reported an increase in circulating IGF-1 during hyperinsulinemia,5
coincident with increased hepatic IGF-1 mRNA and GHR1A mRNA (Butler et al.,6
2003; Rhoads et al., 2004). Two recent reports indicated that NAHF may experience7
more severe insulin resistance compared to NZHF cows during early (Chagas et al.,8
2009) or mid-lactation (Patton et al., 2009). A similar scenario may have occurred in9
the current study where NA cows had moderately greater systemic concentrations of10
insulin, yet the somatotropic axis remained uncoupled for longer due to greater insulin11
resistance in this strain.12
13
In both strains, mRNA abundance of IGFBP-1 and IGFBP-2 decreased from d 35 to d14
140, consistent with improving energy balance status (Vicini et al., 1991; Vandehaar15
et al., 1995; Fenwick et al., 2008). Additionally, a negative correlation between16
circulating IGF-1 concentrations and IGFBP-2 mRNA abundance at d 35 was17
observed, in agreement with previous reports (Sharma et al., 1994; Vleurick et al.,18
2000; Fenwick et al., 2008). The mRNA abundance of GHR1A was also significantly19
reduced during mid-lactation compared with early-lactation in the current study. An20
explanation for this is not readily apparent, as cows were in an improved state of EB21
at d 140 compared to d 35. However, the first biopsy was carried out at 35 days post22
partum in the current study, in contrast with biopsy collection on the day of parturition23
in previous studies where substantial increases in GHR1A with advancing stage of24
lactation were reported (Lucy et al., 2001; Lucy et al., 2009). Conversely, Rhoads et25
al. (2008) recently reported no change in GHR1A mRNA abundance in liver tissue26
17
between days 40 and 160 postpartum. However, GHR1A mRNA levels do not always1
reflect abundance of the GHR protein. Rhoads et al., (2007) reported reduced GHR2
protein without corresponding reductions in GHR1A mRNA in liver tissue of3
nutritionally stressed cows. Therefore, our GHR1A expression data may indicate that4
protein translation of GHR1A increases with improving nutrient intake and EB status,5
thus making reduced levels of GHR1A mRNA adequate for efficient hepatic GH6
action.7
8
Both in vitro and gene knockout studies indicate that the effects of GH are primarily9
mediated by the JAK2 and STAT5a and STAT5b proteins (Udy et al., 1997; Teglund10
et al., 1998). GH binding to the GHR results in a conformational change in the GHR11
that activates JAK2, and JAK2 then phosphorylates STAT5b, (Carter-Su and Smit,12
1998). We did not observe any strain, time, or strain by time interaction effects for13
mRNA abundance of Jak2 or STAT5b. SOCS genes are expressed after early14
JAK/STAT signalling and act as negative regulators of transcription (Wormald and15
Hilton, 2004). Previously it has been reported that SOCS3 mRNA in the liver of mice16
is stimulated by GH (Adams et al., 1998; Lieskovska et al., 2003). SOCS-3 is a target17
of the JAK/STAT signalling cascade and causes a negative feedback loop which18
inhibits STAT phosphorylation, thereby inhibiting GH signalling (Ram and Waxman,19
1999). The mRNA abundance of SOCS3 was greater in NZHF compared to NAHF in20
the current study. Additionally, an increase in mRNA expression of SOCS3 was21
observed from d 35 to d 140 during a time of improving EB status. As SOCS genes22
are expressed after early JAK/STAT signalling, the data indicate that this component23
of the GH signalling cascade is more efficient in NZHF compared to NAHF cows,24
and also in mid-lactation compared to early lactation. Collectively, these observations25
paradoxically suggest that greater mRNA abundance of SOCS3 was observed during26
18
efficient coupling of the somatotropic axis. There are few published reports that have1
examined hepatic SOCS3 gene expression in ruminants. Hyatt et al., (2007) reported2
that SOCS3 mRNA abundance was reduced in liver tissue of young adult male sheep3
that had been nutritionally restricted in utero, and this was coupled with reduced GHR4
mRNA expression. Further work examining the abundance and phosphorylation status5
of the protein products of the Jak2, STAT5b and SOCS3 genes is necessary to6
determine if mRNA abundance of these genes corresponds to protein abundance.7
8
Between d 35 and d 140, a reduction in the mRNA abundance of the liver enriched9
transcription factor HNF-4α was observed. HNF-4α is known to play a critical role in10
transcriptional regulation of many liver specific gene promoters, and is necessary for11
the development and proper function of liver tissue (De Simone and Cortese, 1992;12
Sladek, 1993; Costa et al., 2003). Odom et al., (2004) reported that HNF4α was13
involved in the regulation of a large proportion of the liver transcriptome by binding14
directly to almost half of the actively transcribed genes. The transcription factor HNF-15
4α is involved in hepatic GH-dependent signalling mechanisms (Rastegar et al.,16
2000). GHR1A mRNA is only expressed in liver tissue (Lucy et al., 1998; Jiang and17
Lucy, 2001b), and the GHR1A promoter contains a common cis-regulatory DNA18
element for the liver-specific transcription factors HNF-4α and HNF-4γ (Jiang and19
Lucy, 2001a; Lucy et al., 2001; Xu et al., 2004). In the current study, HNF-4α20
expression levels declined as lactation progressed. This is consistent with (Loor et al.,21
2005), who reported that liver HNF-4α mRNA abundance increased from 14 days22
pre-partum to peak at 28 days post-partum, after which time levels began to decrease23
again. Of note, the decline in HNF-4α mRNA abundance between d 35 and 140 was24
mirrored by reductions in GHRtot and GHR1A mRNA.25
26
19
mRNA abundance of the INSR was significantly reduced at d 140 compared to d 35,1
and a significant strain by time interaction for this gene was observed; the decline in2
INSR mRNA abundance between d 35 and d 140 was greater for NAHF compared to3
NZHF. Simultaneously, a trend for a strain by time interaction for IGF-2 was4
observed, whereby IGF-2 tended to decline in NA cows and increase in NZ cows5
between d 35 and d 140, potentially allowing for strain differences in IGF-2 signalling6
through INSR. The physiological importance of the observed changes in INSR and7
IGF-2 gene expression are unclear at present, however, and warrant further study.8
Hepatic ERα mRNA abundance was greater at d 140 compared to d 35 in the current9
study. It is known that activation of the ER results in increased IGF-1/IGF-1R activity10
(Klotz et al., 2002). It has previously been demonstrated that the abundance of ERα11
mRNA in liver tissue is reduced during severe NEB (Fenwick et al., 2008), but the12
importance of this in relation to the functionality of the somatotropic axis is unclear.13
Estradiol-17β administration to steers increases GH-binding in liver tissue (Breier et14
al., 1988); however in the current study ERα mRNA abundance increased from d 3515
to d 140, while GHR1A mRNA abundance was reduced and GHRtot also tended to16
decline. Again further research is necessary to determine the importance of ERα for17
liver IGF-1 synthesis, and the importance of temporal changes in ERα mRNA18
abundance in regulating the somatotropic axis.19
20
CONCLUSION21
The current study investigated the effects of genetic background and stage of lactation22
on key genes regulating the somatotropic axis in two strains of HF cow. During the23
early postpartum period, orchestrated changes in the endocrine system and whole24
body metabolism are necessary to support mammary milk synthesis. Most cows25
experience at least some degree of NEB and consequent body tissue mobilisation26
20
during early lactation, and this is associated with uncoupling of the somatotropic axis.1
Data from this study suggest that early lactation adaptations may have more severe2
effects in the NA compared to the NZ strain of dairy cow. The NZHF strain had3
greater expression of IGF-1 and also tended to have greater mRNA abundance of4
ALS. Coupled with the observation that IGFBP-3 mRNA declined in the NA strain5
between d 35 and d 140, the results suggest that a greater proportion of circulating6
IGF-1 may have been in the stable ternary complex for the NZHF strain. Taken7
together, the results suggest that strain of Holstein-Friesian dairy cow and stage of8
lactation influence expression of genes in the somatotropic axis. These data contribute9
to advancing our understanding of the biological mechanisms regulating the10
somatotropic axis and nutrient partitioning in lactating dairy cows.11
12
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TABLES:2
Table 1. Oligonucleotide primer sequences, PCR product sizes and annealing temperatures for all gene transcripts analysed by real-time RT-PCR3
Gene Primer Sequence 5’-3’ Size(b.p) Accession Annealing temp. (°C)
IGF-2R L
R
CTACGTCAACGGGGACAAGT
TCGTTCTGGAGCTGAAAGGT
102 NM_174352 60.0
IGFBP5 L
R
AAAGAAGCTGACCCAGTCCA
CCCCTGCTCAGATTTCTGTC
99 NM_001105327 60.0
JAK2 L
R
TTGGCAATGACAAACAAGGA
ATCTCATCTGGGCATCCATC
100 XM_865133 60.0
HNF4α L
R
GCTCCATGGTGTTCAAGGAT
CAGCACCAACTCATCAAGGA
119 NM_001015557 59.9
SOCS3 L
R
CCCCCAGGAGAGCCTATTAC
CGGTCTTCCGACAGAGATGT
112 NM_174466 60.1
STAT5b L
R
TGCATCCGCCATATTCTGTA
AGTCGCAGCTCCTCAAATGT
137 NM_174617 60.1
4
Abbreviations: Insulin-like growth factor-2 receptor (IGF-2R); Insulin like growth factor binding protein-5 (IGFBP-5); janus activated kinase 2 (JAK2);5
hepatocyte nuclear factor 4α (HNF4α); suppressor of cytokine signalling-3 (SOCS3); signal transducer and activator of transcription 5b (STAT5b).6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
26
1
Table 2. Real-time RT-PCR analysis for independent strain and time effects. Real-Time RT-PCR Values are back-transformed least square means2
followed by the 95% confidence limits and are expressed as pg per µg of reversed transcribed RNA3
4
STRAIN DAYS POSTPARTUM
Gene NAHF NZHF P value 35 140 P value
IGF-1 0.32 (.23-.44) 0.51 (.37-.72) < 0.05 0.32 (.22-.47) 0.51 (.34-.76) 0.15
IGF-1R 0.004 (.004-.005) 0.005 (.004-.006) 0.30 0.004 (.004-.005) 0.006 (.005-.008) < 0.001
GHRtot 0.51 (.37-.71) 0.47 (.33-.66) 0.71 0.6 (.42-.88) 0.4 (.27-.58) 0.15
GHR1A 0.03 (.02-.04) 0.03 (.02-.04) 0.65 0.04 (.03-.05) 0.02 (.02-.03) < 0.05
IGFBPALS 0.06 (.04-.09) 0.1 (.07-.14) 0.06 0.06 (.04-.09) 0.1 (.07-.16) 0.11
IGF-2 15.0 (11.9-18.9) 14.6 (11.5-18.5) 0.85 14.9 (11.7-18.9) 14.7 (11.5-18.8) 0.95
IGF-2R 0.14 (.13-.16) 0.14 (.13-.16) 0.97 0.16 (.15-.18) 0.13 (.12-.14) < 0.01
IGFBP-1 4.3 (2.8-6.8) 4.3 (2.7-6.8) 0.98 7.7 (4.9-12.3) 2.4 (1.5-3.8) < 0.01
IGFBP-2 3.4 (2.6-4.4) 3.1 (2.3-4.1) 0.62 5.5 (4.0-7.5) 1.9 (1.4-2.6) < 0.001
IGFBP-3 0.48 (.37-.62) 0.5 (.39 -.65) 0.82 0.64 (.49 -.84) 0.38 (.29 -.5) < 0.05
IGFBP-4 0.25 (.21-.30) 0.24 (.2-.29) 0.85 0.25 (.2-.3) 0.24 (.2-.3) 0.93
IGFBP-5 0.23 (.2-.27) 0.23 (.2-.27) 0.98 0.2 (.18-.25) 0.25 (.21-.3) 0.21
IGFBP-6 0.003 (.002-.004) 0.003 (.003-.004) 0.79 .003 (.003-.005) 0.004 (.003-.0005) 0.20
ER-α 0.41 (.37-.47) 0.46 (.41-.53) 0.22 0.36 (.31-.4) 0.54 (.47-.61) < 0.001
INSR 0.03 (.03-.04) 0.02 (0.02-.03) 0.18 0.031 (.03-.04) 0.025 (.02-.03) < 0.01
HNF4-α 0.3 (.26-.35) 0.32 (.27-.37) 0.56 0.47 (.4-.54) 0.2 (.18-.24) < 0.001
SOCS3 0.5 (.41-.6) 0.8 (.66-.98) < 0.01 0.4 (.33-.49) 0.99 (.8-1.23) < 0.001
JAK2 0.0004 (.0002-.0005) 0.0005 (.0003-.0007) 0.28 0.0005 (.0003-.0007) 0.0004 (.0002-.0006) 0.45
STAT5b 0.1 (.095-.11) 0.1 (.09-.11) 0.51 0.11 (.1-.12) 0.1 (.09-1.1) 0.29
5
Abbreviations: Insulin-like growth factor 1 and 2 (IGF-1 and 2) and receptors (IGF-1R and IGF-2R); Insulin like growth factor binding proteins 1-6 (IGFBP-1-6
6) and acid labile subunit (IGFBP-ALS); growth hormone receptor (GHRtot) and 1A variant (GHR1A); estrogen receptor α (ERα); insulin receptor type A7
(INSR); janus activated kinase 2 (JAK2); hepatocyte nuclear factor 4α (HNF4α); suppressor of cytokine signalling-3 (SOCS3); signal transducer and activator of8
transcription 5b (STAT5b).9
27
Table 3. Strain by time (S*T) interaction effects with respective P-values, where NA 35 and NA1
140 represent NAHF strain at d 35 and d 140 respectively and similarly NZ 35 and NZ 1402
denote NZHF at d 35 and d 140 respectively. Values are back-transformed least square means3
followed by the 95% confidence limits and are expressed as pg per µg of reversed transcribed4
RNA.5
Gene S*T NA 35 S*T NA 140 S*T NZ 35 S*T NZ 140 P value
IGF-1 0.25 (.14-.42) 0.41 (.24-.71) 0.42 (.26-.69) 0.62 (.38-1.04) 0.79
IGF-1R 0.003 (.003-.005) 0.006 (.004-.008) 0.004 (.003-.005)a 0.007 (.006-.01)b 0.52
GHRtot 0.61 (.36-1.03) 0.43 (.25-.72) 0.59 (.37-.95) 0.37 (.23-.6) 0.80
GHR1A 0.03 (.02-.05) 0.02 (.02-.03) 0.04 (.02-.05) 0.02 (.02-.03) 0.58
IGFBPALS 0.05 (.03-.09) 0.08 (.04-.13) 0.07 (.04-.12) 0.14 (.08-.24) 0.58
IGF-2 17.2 (11.9-24.7) 13.1 (9.2-18.6) 12.9 (9.3-17.9) 16.5 (11.6-23.3) 0.15
IGF-2R 0.16 (.14-.19) 0.12 (.11-.14) 0.16 (.14-.18) 0.13 (.11-.15) 0.50
IGFBP-1 6.4 (3.4-12.2) 2.9 (1.5-5.6) 9.4 (5.3-16.7)a 2.0 (1.1-3.6)b 0.12
IGFBP-2 6.0 (3.8-9.2)a 1.9-(1.2-3.0)b 5.1 (3.4-7.4)a 1.9 (1.3-2.8)b 0.68
IGFBP-3 0.74 (0.5-1.1)a 0.32 (.22-.46)b 0.56 (.39-.8) 0.45 (.31-.66) 0.11
IGFBP-4 0.3 (.22-.4) 0.21 (.16-.27) 0.2 (.16-.27) 0.29 (.22-.38) < 0.05
IGFBP-5 0.2 (.16-.27) 0.26 (.2-.33) 0.22 (.17-.27) 0.25 (.19-.32) 0.74
IGFBP-6 0.003 (.002-.005) 0.003 (.002-.004) 0.002 (.002-.003) 0.004 (.003-.006) 0.06
ER-α 0.34 (.28-.41)a 0.51 (.42-.61)b 0.37 (.31-.45)a 0.57 (.47-.68)b 0.93
INSR 0.04 (.03-.06)a 0.02 (.02-.03)b 0.03 (.02-.03) 0.02 (.02-.03) < 0.05
HNF4-α 0.44 (.36-.55)a 0.2 (.16-.25)b 0.49 (.4-.6)a 0.2 (.17-.25)b 0.62
SOCS3 0.25 (.19-.34)Aa 0.97 (.72-1.3)b 0.64 (.48-.84)B 1.0 (.75-1.4) < 0.01
JAK2 0.0003 (.0002-.0006) 0.0004 (.0002-.0007) 0.0006 (.0004-.001) 0.0004 (.0002-.0007) 0.34
STAT5b 0.12 (.095-.13) 0.1 (.09-.11) 0.1 (.09-.12) 0.1 (.09-.11) 0.64
6
Abbreviations: Insulin-like growth factor 1 and 2 (IGF-1 and 2) and receptors (IGF-1R and IGF-2R);7
Insulin like growth factor binding proteins 1-6 (IGFBP-1-6) and acid labile subunit (IGFBP-ALS);8
growth hormone receptor (GHRtot) and 1A variant (GHR1A); estrogen receptor α (ERα); insulin9
receptor type A (INSR); janus activated kinase 2 (JAK2); hepatocyte nuclear factor 4α (HNF4α);10
suppressor of cytokine signalling-3 (SOCS3); signal transducer and activator of transcription 5b11
(STAT5b).12
ab Within strain means not sharing a common superscript differ between timepoints (P < 0.05).13
AB Within timepoint means not sharing a common superscript differ between strains (P < 0.05).14
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Table 4. Linearity ( r2), efficiency (E) and % intra-assay variation of real-time RT PCR2
reactions3
4
Gene r2 E1 % Variation2
IGF-1 0.996 1.09 ± 0.7
IGF-1R 0.999 1.09 ± 3.8
GHRtot 0.987 0.85 ± 26.5
GHR1A 0.99 1.17 ± 3.4
IGFBPALS 0.991 1.28 ± 3.3
IGF-2 0.998 0.76 ± 12.8
IGF-2R 0.996 1.23 ± 7.1
IGFBP-1 0.991 1.00 ± 0.5
IGFBP-2 0.995 0.92 ± 0.5
IGFBP-3 0.997 0.95 ± 13.9
IGFBP-4 0.998 0.95 ± 10.1
IGFBP-5 0.994 1.32 ± 6.8
IGFBP-6 0.999 0.90 ± 7.4
ER-α 0.995 1.04 ± 10.0
INSR 0.999 0.89 ± 3.8
HNF4-α 0.993 1.15 ± 21.6
SOCS3 0.997 0.97 ± 12.5
JAK2 0.983 1.41 ± 4.7
STAT5b 0.986 1.38 ± 6.9
5
Insulin-like growth factor 1 and 2 (IGF-1 and 2) and receptors (IGF-1R and IGF-2R); Insulin like growth6
factor binding proteins 1-6 (IGFBP-1-6) and acid labile subunit (IGFBP-ALS); growth hormone receptor7
(GHRtot) and 1A variant (GHR1A); estrogen receptor α (ERα); insulin receptor type A (INSR); janus8
activated kinase 2 (JAK2); hepatocyte nuclear factor 4α (HNF4α); suppressor of cytokine signalling-39
(SOCS3); signal transducer and activator of transcription 5b (STAT5b).10
1 Efficiency (E) = 10(-1/slope) – 111
2 % Variation = [(E + 1)SD - 1] × 10012
13
14
15
